Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Real-World Experience of Bevacizumab as First-Line Treatment for Ovarian Cancer: The GINECO ENCOURAGE Cohort of 468 French Patients.
Front Pharmacol. 2021 Sep 20;12:711813. doi: 10.3389/fphar.2021.711813. eCollection 2021.
Front Pharmacol. 2021.
PMID: 34616296
Free PMC article.
Model-Based Quantification of Impact of Genetic Polymorphisms and Co-Medications on Pharmacokinetics of Tamoxifen and Six Metabolites in Breast Cancer.
Puszkiel A, Arellano C, Vachoux C, Evrard A, Le Morvan V, Boyer JC, Robert J, Delmas C, Dalenc F, Debled M, Venat-Bouvet L, Jacot W, Dohollou N, Bernard-Marty C, Laharie-Mineur H, Filleron T, Roché H, Chatelut E, Thomas F, White-Koning M.
Puszkiel A, et al. Among authors: laharie mineur h.
Clin Pharmacol Ther. 2021 May;109(5):1244-1255. doi: 10.1002/cpt.2077. Epub 2020 Nov 10.
Clin Pharmacol Ther. 2021.
PMID: 33047329
Clinical Trial.
Item in Clipboard
[Bilateral ductal carcinoma in situ of the breast: independent events or bilateral disease?].
André G, Tunon-de-Lara C, Macgrogan G, Laharie-Mineur H, Bussieres JE, Valentin F, Barreau B, Dilhuydy MH, Dilhuydy JM, Mauriac L, Debled M, Durand M, Mathoulin S, Avril A.
André G, et al. Among authors: laharie mineur h.
J Gynecol Obstet Biol Reprod (Paris). 2007 May;36(3):260-6. doi: 10.1016/j.jgyn.2007.02.002. Epub 2007 Mar 21.
J Gynecol Obstet Biol Reprod (Paris). 2007.
PMID: 17376610
Free article.
French.
Item in Clipboard
[Potential risk and benefit of the combination of trastuzumab to chemotherapy and radiation therapy in non-metastatic breast cancer].
Belkacémi Y, Laharie-Mineur H, Gligorov J, Azria D.
Belkacémi Y, et al. Among authors: laharie mineur h.
Cancer Radiother. 2007 Sep;11(5):266-75. doi: 10.1016/j.canrad.2007.04.002. Epub 2007 Jul 20.
Cancer Radiother. 2007.
PMID: 17644449
Review.
French.
Item in Clipboard
Concurrent trastuzumab with adjuvant radiotherapy in HER2-positive breast cancer patients: acute toxicity analyses from the French multicentric study.
Belkacémi Y, Gligorov J, Ozsahin M, Marsiglia H, De Lafontan B, Laharie-Mineur H, Aimard L, Antoine EC, Cutuli B, Namer M, Azria D.
Belkacémi Y, et al. Among authors: laharie mineur h.
Ann Oncol. 2008 Jun;19(6):1110-6. doi: 10.1093/annonc/mdn029. Epub 2008 Mar 15.
Ann Oncol. 2008.
PMID: 18344537
Free article.
Clinical Trial.
Item in Clipboard
6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial.
Pivot X, Romieu G, Debled M, Pierga JY, Kerbrat P, Bachelot T, Lortholary A, Espié M, Fumoleau P, Serin D, Jacquin JP, Jouannaud C, Rios M, Abadie-Lacourtoisie S, Venat-Bouvet L, Cany L, Catala S, Khayat D, Gambotti L, Pauporté I, Faure-Mercier C, Paget-Bailly S, Henriques J, Grouin JM; PHARE trial investigators.
Pivot X, et al.
Lancet. 2019 Jun 29;393(10191):2591-2598. doi: 10.1016/S0140-6736(19)30653-1. Epub 2019 Jun 6.
Lancet. 2019.
PMID: 31178155
Clinical Trial.
Item in Clipboard
6 months versus 12 months of adjuvant trastuzumab for patients with HER2-positive early breast cancer (PHARE): a randomised phase 3 trial.
Pivot X, Romieu G, Debled M, Pierga JY, Kerbrat P, Bachelot T, Lortholary A, Espié M, Fumoleau P, Serin D, Jacquin JP, Jouannaud C, Rios M, Abadie-Lacourtoisie S, Tubiana-Mathieu N, Cany L, Catala S, Khayat D, Pauporté I, Kramar A; PHARE trial investigators.
Pivot X, et al.
Lancet Oncol. 2013 Jul;14(8):741-8. doi: 10.1016/S1470-2045(13)70225-0. Epub 2013 Jun 11.
Lancet Oncol. 2013.
PMID: 23764181
Clinical Trial.
Item in Clipboard
Cite
Cite